AT EN
About us     The Company     The History     Management     B-Corp Certification     Mission & Values     Annual and Sustainability Report Code of Conduct Therapy Areas      Respiratory      Neonatology      Transplantmedicine      Rare Diseases      Other therapeutic fields      Special Care Contact Service     Customer Service     Patientservice     Medical Suggestions Pharmacovigilance Products Sustainability     Our approach     We ACT - Sustainability Manifesto     Environment     Supply Chain Sustainability     Chiesi Foundation     Sustainability Report Working for Chiesi     Chiesi as Employer     Job Posting Compliance     Ethics and Transparency     SpeakUp&BeHeard Media     Awards Compliance
  • Contact
  • |
  • Pharmacovigilance
  • |
  • Chiesi Group
  • AT
  • EN
logo_sito
Welcome to Chiesi
Austria
Enter at least 3 characters
  • About us
    • The Company
    • The History
    • Management
    • B-Corp Certification
    • Mission & Values
    • Annual and Sustainability Report
  • Therapy Areas
    • Respiratory
    • Neonatology
    • Transplantmedicine
    • Rare Diseases
    • Other therapeutic fields
    • Special Care
  • Service
    • Customer Service
    • Patientservice
    • Medical Suggestions
  • Products
  • Sustainability
    • Our approach
    • We ACT - Sustainability Manifesto
    • Environment
    • Supply Chain Sustainability
    • Chiesi Foundation
    • Sustainability Report
  • Working for Chiesi
    • Chiesi as Employer
    • Job Posting
  • Compliance
    • Ethics and Transparency
    • SpeakUp&BeHeard
  • Media
    • Awards
Home page > Sitemap
 
as am axl
print
email

Authorize the processing of personal data
Edit email address
Invalid email
Email Sent
Authorize the processing of personal data
  • Home page
  • About us
    • - The Company
    • - The History
    • - Management
    • - B-Corp Certification
    • - Mission & Values
    • - Annual and Sustainability Report
  • Therapy Areas
    • - Atemwegserkrankungen
    • - Neonatologie
    • - Transplantmedizin
    • - Rare Diseases
    • - Weitere Therapiefelder
    • - Critical Care
  • Service
    • - Customer Service
    • - Patientservice
    • - Medical Suggestions
  • Sustainability
    • - Our approach
    • - We ACT - Sustainability Manifesto
    • - Environment
    • - Supply Chain Sustainability
    • - Chiesi Foundation
    • - Sustainability Report
  • Working for Chiesi
    • - Chiesi as Employer
    • - Job Posting
  • Compliance
    • - Ethics and Transparency
    • - SpeakUp&BeHeard
  • Media
    • - Awards
  • Products
    • - Curosurf®
    • - Envarsus®
    • - Kengrexal®
    • - Procysbi®
    • - Elfabrio®
    • - Filsuvez®
    • - Lojuxta®
    • - Myalepta®
    • - Foster pMDI®
    • - Foster Nexthaler®
    • - Monuril®
    • - Prolastin®
    • - Trimbow®
    • - Bramitob®
    • - Cleviprex®
    • - Ferriprox®
    • - Raxone®
    • - Peyona®
    • - Quinsair®
    • - Startonyl®
    • - Lamzede®
    • - Hyaneb®
  • Contact
  • Pharmacovigilance
© 2025 Chiesi Pharmaceuticals GmbH
Gonzagagasse 16/16 1010 Wien
Tel. +43.1.407 39 19 – 0
Email: info.at@chiesi.com
  • Sitemap
  • AGB/AEB
  • Imprint
  • privacy
  • Disclaimer
  • Credits
  • Cookies

PHARMACOVIGILANCE

TO REPORT ADVERSE DRUG EVENTS/REACTIONS PLEASE CLICK HERE

CHIESI ON THE WEB
mappa
logofooter
CHIESI ON THE WEB
Austria
Chiesi Pharmaceuticals GmbH
Belgium
Chiesi sa
Brazil
Chiesi Farmacêutica Ltda
Bulgaria
Chiesi Bulgaria Ltd.
China
Chiesi Pharmaceutical (Shanghai) Co., Ltd
Czech Republic
Chiesi CZ s.r.o.
France
Chiesi S.A.
Germany
Chiesi GmbH
Greece
Chiesi Hellas Pharmaceuticals S.A.
Hungary
Chiesi Hungary Kft.
Italy
-
Mexico
Chiesi Mexico S.A. de C.V.
Pakistan
Chiesi Pharmaceuticals (Pvt) Limited
Poland
Chiesi Polonia
Romania
Chiesi România S.r.l.
Russian Federetion
Chiesi Pharmaceuticals LLC
Slovak Republic
Chiesi Slovakia s.r.o
Slovenia
Chiesi Slovenija, d.o.o
Spain
Chiesi España S.A.
Sweden
Chiesi Pharma AB
The Netherlands
Chiesi Pharmaceuticals B.V.
Turkey
Chiesi İlaçTicaret Limited Sirketi  A.Ş.
United Kingdom
Chiesi Ltd
United States
Chiesi Usa Inc.